Page 47 - Read Online

Strassheim et al. Vessel Plus 2018;2:29 I http://dx.doi.org/10.20517/2574-1209.2018.44 Page 19 of 22

166. Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S. Role of leukotriene B4 in monocrotaline-induced pulmonary
hypertension. Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:160-6.
167. Albertini M, Clement MG. In pigs, inhaled nitric oxide (NO) counterbalances PAF-induced pulmonary hypertension. Prostaglandins
Leukot Essent Fatty Acids 1994;51:357-62.
168. Ono S, Voelkel NF. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension. J Appl Physiol (1985)
1991;71:2483-92.
169. Smallbone BW, Taylor NE, McDonald JW. Effects of L-652,731, a platelet-activating factor (PAF) receptor antagonist, on PAF- and
complement-induced pulmonary hypertension in sheep. J Pharmacol Exp Ther 1987;242:1035-40.
170. Lu A, Zuo C, He Y, Chen G, Piao L, Zhang J, Xiao B, Shen Y, Tang J, Kong D, Alberti S, Chen D, Zuo S, Zhang Q, Yan S, Fei X, Yuan
F, Zhou B, Duan S, Yu Y, Lazarus M, Su Y, Breyer RM, Funk CD, Yu Y. EP3 receptor deficiency attenuates pulmonary hypertension
through suppression of Rho/TGF-beta1 signaling. J Clin Invest 2015;125:1228-42.
171. Toki S, Zhou W, Goleniewska K, Reiss S, Dulek DE, Newcomb DC, Lawson WE, Peebles RS, Jr. Endogenous PGI2 signaling
through IP inhibits neutrophilic lung inflammation in LPS-induced acute lung injury mice model. Prostaglandins Other Lipid Mediat
2018;136:33-43.
172. Zhou W, Hashimoto K, Goleniewska K, O’Neal JF, Ji S, Blackwell TS, Fitzgerald GA, Egan KM, Geraci MW, Peebles RS, Jr.
Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol
2007;178:702-10.
173. Miyata M, Ueno Y, Sekine H, Ito O, Sakuma F, Koike H, Nishio S, Nishimaki T, Kasukawa R. Protective effect of beraprost sodium, a
stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension. J Cardiovasc Pharmacol 1996;27:20-
6.
174. Pickworth J, Rothman A, Iremonger J, Casbolt H, Hopkinson K, Hickey PM, Gladson S, Shay S, Morrell NW, Francis SE, West JD,
Lawrie A. Differential IL-1 signaling induced by BMPR2 deficiency drives pulmonary vascular remodeling. Pulm Circ 2017;7:768-76.
175. Good RB, Gilbane AJ, Trinder SL, Denton CP, Coghlan G, Abraham DJ, Holmes AM. Endothelial to mesenchymal transition
contributes to endothelial dysfunction in pulmonary arterial hypertension. Am J Pathol 2015;185:1850-8.
176. Nelin LD, White HA, Jin Y, Trittmann JK, Chen B, Liu Y. The Src family tyrosine kinases src and yes have differential effects
on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells. Am J Physiol Lung Cell Mol Physiol
2016;310:L880-8.
177. Yu XH, Tang ZB, Liu LJ, Qian H, Tang SL, Zhang DW, Tian GP, Tang CK. Apelin and its receptor APJ in cardiovascular diseases. Clin
Chim Acta 2014;428:1-8.
178. Wu Q, Wang HY, Li J, Zhou P, Wang QL, Zhao L, Fan R, Wang YM, Xu XZ, Yi DH, Yu SQ, Pei JM. Kappa-opioid receptor stimulation
improves endothelial function in hypoxic pulmonary hypertension. PLoS One 2013;8:e60850.
179. Zhou Y, Wang Y, Wang X, Tian X, Zhang S, Yang F, Guo H, Fan R, Feng N, Jia M, Gu X, Wang Y, Li J, Pei J. The protective effects
of kappa-opioid receptor stimulation in hypoxic pulmonary hypertension involve inhibition of autophagy through the AMPK-MTOR
pathway. Cell Physiol Biochem 2017;44:1965-79.
180. Zhang J, Liu Q, Fang Z, Hu X, Huang F, Tang L, Zhou S. Hypoxia induces the proliferation of endothelial progenitor cells via
upregulation of Apelin/APLNR/MAPK signaling. Mol Med Rep 2016;13:1801-6.
181. Zhang H, Gong Y, Wang Z, Jiang L, Chen R, Fan X, Zhu H, Han L, Li X, Xiao J, Kong X. Apelin inhibits the proliferation and
migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia. J Cell Mol Med
2014;18:542-53.
182. Zhang J, Liu Q, Hu X, Fang Z, Huang F, Tang L, Zhou S. Apelin/APJ signaling promotes hypoxia-induced proliferation of endothelial
progenitor cells via phosphoinositide-3 kinase/Akt signaling. Mol Med Rep 2015;12:3829-34.
183. Zheng H, Fu G, Dai T, Huang H. Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via
PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007;50:274-80.
184. Foresta C, De Toni L, Di Mambro A, Garolla A, Ferlin A, Zuccarello D. The PDE5 inhibitor sildenafil increases circulating endothelial
progenitor cells and CXCR4 expression. J Sex Med 2009;6:369-72.
185. Yaoita N, Shirakawa R, Fukumoto Y, Sugimura K, Miyata S, Miura Y, Nochioka K, Miura M, Tatebe S, Aoki T, Yamamoto S, Satoh K,
Kimura T, Shimokawa H, Horiuchi H. Platelets are highly activated in patients of chronic thromboembolic pulmonary hypertension.
Arterioscler Thromb Vasc Biol 2014;34:2486-94.
186. Diebold I, Djordjevic T, Hess J, Gorlach A. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of
plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription. Thromb Haemost
2008;100:1021-8.
187. Banerjee I, Fuseler JW, Price RL, Borg TK, Baudino TA. Determination of cell types and numbers during cardiac development in the
neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol 2007;293:H1883-91.
188. Sun F, Lu Z, Zhang Y, Geng S, Xu M, Xu L, Huang Y, Zhuang P, Zhang Y. Stagedependent changes of beta2adrenergic receptor
signaling in right ventricular remodeling in monocrotalineinduced pulmonary arterial hypertension. Int J Mol Med 2018;41:2493-504.
189. Wang S, Wu J, You J, Shi H, Xue X, Huang J, Xu L, Jiang G, Yuan L, Gong X, Luo H, Ge J, Cui Z, Zou Y. HSF1 deficiency accelerates
the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated
impairment of cardiac angiogenesis. J Mol Cell Cardiol 2018;118:193-207.
190. Zhao Y, Yan M, Chen C, Gong W, Yin Z, Li H, Fan J, Zhang XA, Wang DW, Zuo H. MiR-124 aggravates failing hearts by suppressing
CD151-facilitated angiogenesis in heart. Oncotarget 2018;9:14382-96.